First FDA-Cleared Respirators for General Public Use in Public Health Medical Emergencies Now Available From 3M
Posted on: Friday, 16 May 2008, 12:00 CDT
Consumers concerned about an influenza outbreak can breathe a little easier: 3M has just released two new NIOSH N95 respirators for use by the general public in public health medical emergencies.
These two respirators--3M™ Particulate Respirator 8612F and 3M™ Particulate Respirator 8670F--are unique because they are the first to receive clearance by the U.S. Food & Drug Administration (FDA) to reduce exposure to airborne germs during a public health medical emergency such as an influenza pandemic. The FDA outlined a special clearance process for N95 respirators used by the general public in public health medical emergencies in order to provide reasonable assurance of their safety and effectiveness.
Although use of respirators is only one of several precautions that can be taken in response to a public health medical emergency, "The release of these FDA-N95 respirators is a significant step in providing the public with guidance and products needed to help reduce exposure to airborne germs," said Julie Bushman, division vice-president, 3M Occupational Health and Environmental Safety Division.
According to Bushman, 3M is taking steps to ensure the respirators are readily available to the public. "The need has grown as more people realize the importance of planning ahead for a public health medical emergency," Bushman said.
3M™ Particulate Respirator 8612F and 3M™ Particulate Respirator 8670F can be purchased from one of the many medical, safety and industrial distributors that carry 3M products. Additionally, these new products will be available under the Nexcare™ brand in select retail pharmacies. Both products can also be purchased from the company's online store, www.3MeStore.com, or by calling 1-800-234-8068.
For technical information about proper use of these 3M respirators, visit www.my3MN95.com or call 1-888-436-3636.
About 3M
A recognized leader in research and development, 3M produces thousands of innovative products for dozens of diverse markets. 3M's core strength is applying its more than 40 distinct technology platforms -- often in combination -- to a wide array of customer needs. With $25 billion in sales, 3M employs 75,000 people worldwide and has operations in more than 60 countries.
Source: Business Wire
Related Articles
- Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products
- avVaa World Health Care Products Inc. Announces Third Media Test
- Access to Care Leads Americans' Priorities in First-Ever Public Study of Health Value
- Quick-Med Technologies, Inc. Signs Joint Development Agreement With a Leading Provider of Health Care Products
- Health Enhancement Products Announces Peer-Reviewed Publication of a Clinical Study Involving Metabolic Syndrome and Markers of Cardiovascular Health
- National Medical, Health Care and Public Health Groups Take Challenge of Clean Air Mercury Rules to Higher Court
- Health Cash Product Profiles 2006 Offers a Profile of Every Known Health Cash Product in the UK Health Cash Market From a Customer Perspective
- ALR Technologies Medication Compliance Reminder Product Selected for Use in Kenya Research Study for AIDS Patients
- Health Enhancement Products Announces Appointment of Ex-White House Chief of Staff, Hamilton Jordan, to Its Scientific Advisory Board; Jordan to Also Act As a Consultant to the Company
- Society of Prospective Medicine Group Creates Ties With the Institute for Health and Productivity Management
 |
 |
User Comments (0)
RSS Feeds